• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清磷脂脂肪酸与前列腺癌风险:前列腺癌预防试验的结果。

Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.

机构信息

Department of Epidemiology, University of Washington, Seattle, Washington, USA.

出版信息

Am J Epidemiol. 2011 Jun 15;173(12):1429-39. doi: 10.1093/aje/kwr027. Epub 2011 Apr 24.

DOI:10.1093/aje/kwr027
PMID:21518693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3145396/
Abstract

Inflammation may be involved in prostate cancer development and progression. This study examined the associations between inflammation-related phospholipid fatty acids and the 7-year-period prevalence of prostate cancer in a nested case-control analysis of participants, aged 55-84 years, in the Prostate Cancer Prevention Trial during 1994-2003. Cases (n = 1,658) were frequency matched to controls (n = 1,803) on age, treatment, and prostate cancer family history. Phospholipid fatty acids were extracted from serum, and concentrations of ω-3, ω-6, and trans-fatty acids (TFAs) were expressed as proportions of the total. Logistic regression models estimated odds ratios and 95% confidence intervals of associations of fatty acids with prostate cancer by grade. No fatty acids were associated with low-grade prostate cancer risk. Docosahexaenoic acid was positively associated with high-grade disease (quartile 4 vs. 1: odds ratio (OR) = 2.50, 95% confidence interval (CI): 1.34, 4.65); TFA 18:1 and TFA 18:2 were linearly and inversely associated with risk of high-grade prostate cancer (quartile 4 vs. 1: TFA 18:1, OR = 0.55, 95% CI: 0.30, 0.98; TFA 18:2, OR = 0.48, 95% CI: 0.27, 0.84). The study findings are contrary to those expected from the pro- and antiinflammatory effects of these fatty acids and suggest a greater complexity of effects of these nutrients with regard to prostate cancer risk.

摘要

炎症可能与前列腺癌的发生和发展有关。本研究通过巢式病例对照分析,探讨了炎症相关磷脂脂肪酸与前列腺癌发生的相关性。研究对象为参加 1994-2003 年前列腺癌预防试验的年龄在 55-84 岁的参与者,共纳入病例 1658 例,按年龄、治疗和前列腺癌家族史与对照 1803 例进行频数匹配。从血清中提取磷脂脂肪酸,并用 ω-3、ω-6 和反式脂肪酸(TFAs)的比例表示脂肪酸的浓度。采用 logistic 回归模型估计脂肪酸与前列腺癌分级的关联的比值比(OR)及其 95%置信区间(CI)。没有脂肪酸与低级别前列腺癌风险相关。二十二碳六烯酸(docosahexaenoic acid)与高级别疾病呈正相关(四分位数 4 与 1 相比:OR=2.50,95%CI:1.34-4.65);18:1 反式脂肪酸(TFA 18:1)和 18:2 反式脂肪酸(TFA 18:2)与高级别前列腺癌风险呈线性负相关(四分位数 4 与 1 相比:TFA 18:1,OR=0.55,95%CI:0.30-0.98;TFA 18:2,OR=0.48,95%CI:0.27-0.84)。研究结果与这些脂肪酸的抗炎和促炎作用的预期结果相反,表明这些营养素对前列腺癌风险的影响更为复杂。

相似文献

1
Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.血清磷脂脂肪酸与前列腺癌风险:前列腺癌预防试验的结果。
Am J Epidemiol. 2011 Jun 15;173(12):1429-39. doi: 10.1093/aje/kwr027. Epub 2011 Apr 24.
2
Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.SELECT 试验中血浆磷脂脂肪酸与前列腺癌风险的关系。
J Natl Cancer Inst. 2013 Aug 7;105(15):1132-41. doi: 10.1093/jnci/djt174. Epub 2013 Jul 10.
3
Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial.前列腺癌预防试验安慰剂组中血清磷脂脂肪酸与前列腺内炎症的关联
Cancer Prev Res (Phila). 2015 Jul;8(7):590-6. doi: 10.1158/1940-6207.CAPR-14-0398. Epub 2015 Apr 29.
4
Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.血清视黄醇和类胡萝卜素浓度与前列腺癌风险:前列腺癌预防试验的结果。
Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1507-15. doi: 10.1158/1055-9965.EPI-15-0394. Epub 2015 Aug 12.
5
Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial.良性前列腺增生症和前列腺癌的症状关联:前列腺癌预防试验的结果。
Am J Epidemiol. 2011 Jun 15;173(12):1419-28. doi: 10.1093/aje/kwq493. Epub 2011 May 3.
6
The association of fatty acids with prostate cancer risk.脂肪酸与前列腺癌风险的关联。
Prostate. 2001 Jun 1;47(4):262-8. doi: 10.1002/pros.1070.
7
Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer.血清磷脂中脂肪酸的诊断前水平:ω-3和ω-6脂肪酸与前列腺癌风险
Int J Cancer. 1997 May 16;71(4):545-51. doi: 10.1002/(sici)1097-0215(19970516)71:4<545::aid-ijc7>3.0.co;2-u.
8
Comparison of fatty acid profiles in the serum of patients with prostate cancer and benign prostatic hyperplasia.前列腺癌患者与良性前列腺增生患者血清中脂肪酸谱的比较。
Clin Biochem. 1999 Aug;32(6):405-9. doi: 10.1016/s0009-9120(99)00036-3.
9
RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial.关于:SELECT试验中血清磷脂脂肪酸与前列腺癌风险
J Natl Cancer Inst. 2014 Apr;106(4):dju024. doi: 10.1093/jnci/dju024. Epub 2014 Mar 31.
10
RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial.关于:SELECT试验中血清磷脂脂肪酸与前列腺癌风险
J Natl Cancer Inst. 2014 Apr;106(4):dju023. doi: 10.1093/jnci/dju023. Epub 2014 Mar 31.

引用本文的文献

1
Dietary Omega-3 intake may slow prostate cancer progression and reduce mortality risk: evidence from prostate, lung, colorectal, and ovarian cancer screening trial.膳食中ω-3脂肪酸的摄入可能会减缓前列腺癌的进展并降低死亡风险:来自前列腺、肺、结肠直肠和卵巢癌筛查试验的证据。
Front Nutr. 2025 Jul 21;12:1623295. doi: 10.3389/fnut.2025.1623295. eCollection 2025.
2
Effects of Docosahexaenoic Acid on Prostate Cancer.二十二碳六烯酸对前列腺癌的影响。
J Xenobiot. 2025 Jul 4;15(4):111. doi: 10.3390/jox15040111.
3
Understanding the Role of Polyunsaturated Fatty Acids in the Development and Prevention of Cancer.了解多不饱和脂肪酸在癌症发展和预防中的作用。
Cancer Treat Res. 2024;191:57-93. doi: 10.1007/978-3-031-55622-7_3.
4
Functional Lipids and Cardiovascular Disease Reduction: A Concise Review.功能性脂质与心血管疾病的降低:简要综述。
Nutrients. 2024 Jul 28;16(15):2453. doi: 10.3390/nu16152453.
5
Metabolic Patterns of High-Invasive and Low-Invasive Oral Squamous Cell Carcinoma Cells Using Quantitative Metabolomics and C-Glucose Tracing.采用定量代谢组学和 C-葡萄糖示踪技术研究高侵袭性和低侵袭性口腔鳞状细胞癌细胞的代谢模式。
Biomolecules. 2023 Dec 18;13(12):1806. doi: 10.3390/biom13121806.
6
Lipid-lowering drugs and cancer: an updated perspective.降脂药物与癌症:最新视角。
Pharmacol Rep. 2024 Feb;76(1):1-24. doi: 10.1007/s43440-023-00553-6. Epub 2023 Nov 28.
7
Effect of omega-3 fatty acid diet on prostate cancer progression and cholesterol efflux in tumor-associated macrophages-dependence on GPR120.ω-3 脂肪酸饮食对前列腺癌进展和肿瘤相关巨噬细胞胆固醇外排的影响——依赖于 GPR120。
Prostate Cancer Prostatic Dis. 2024 Dec;27(4):700-708. doi: 10.1038/s41391-023-00745-4. Epub 2023 Oct 23.
8
A Potential Role for Gut Microbes in Mediating Effects of Omega-3 Fatty Acids in Inflammatory Bowel Diseases: A Comprehensive Review.肠道微生物在介导ω-3 脂肪酸对炎症性肠病的作用中的潜在作用:全面综述。
Curr Microbiol. 2023 Oct 8;80(11):363. doi: 10.1007/s00284-023-03482-y.
9
Impact of modifiable lifestyle risk factors for prostate cancer prevention: a review of the literature.可改变的生活方式风险因素对前列腺癌预防的影响:文献综述
Front Oncol. 2023 Sep 8;13:1203791. doi: 10.3389/fonc.2023.1203791. eCollection 2023.
10
Impacts of Fortifying Nile Tilapia () Diet with Different Strains of Microalgae on Its Performance, Fillet Quality and Disease Resistance to Considering the Interplay between Antioxidant and Inflammatory Response.用不同微藻菌株强化尼罗罗非鱼()日粮对其生长性能、鱼片品质及对的抗病力的影响:考虑抗氧化与炎症反应之间的相互作用
Antioxidants (Basel). 2022 Nov 3;11(11):2181. doi: 10.3390/antiox11112181.

本文引用的文献

1
Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort.专业补充剂与 VITAL 队列中前列腺癌的风险。
Nutr Cancer. 2011;63(4):573-82. doi: 10.1080/01635581.2011.553022.
2
Fish consumption and prostate cancer risk: a review and meta-analysis.鱼类摄入与前列腺癌风险:综述与荟萃分析。
Am J Clin Nutr. 2010 Nov;92(5):1223-33. doi: 10.3945/ajcn.2010.29530. Epub 2010 Sep 15.
3
Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial.饮食、补充剂使用与前列腺癌风险:前列腺癌预防试验的结果。
Am J Epidemiol. 2010 Sep 1;172(5):566-77. doi: 10.1093/aje/kwq148. Epub 2010 Aug 6.
4
Trans fats in America: a review of their use, consumption, health implications, and regulation.美国的反式脂肪:对其使用、消费、健康影响及监管的综述。
J Am Diet Assoc. 2010 Apr;110(4):585-92. doi: 10.1016/j.jada.2009.12.024.
5
Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis.使用非甾体抗炎药与前列腺癌风险:一项荟萃分析。
Int J Cancer. 2010 Oct 1;127(7):1680-91. doi: 10.1002/ijc.25186.
6
Chemotherapeutic Properties of n-3 Polyunsaturated Fatty Acids - Old Concepts and New Insights.n-3多不饱和脂肪酸的化疗特性——旧概念与新见解
Immunol Endocr Metab Agents Med Chem. 2009 Mar 1;9(1):38-44. doi: 10.2174/187152209788009841.
7
Anti-inflammatory drugs, antioxidants, and prostate cancer prevention.抗炎药物、抗氧化剂与前列腺癌预防
Curr Opin Pharmacol. 2009 Aug;9(4):419-26. doi: 10.1016/j.coph.2009.06.002. Epub 2009 Jul 1.
8
Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation.膳食中的二十二碳六烯酸和二十碳五烯酸:新兴的炎症介质
Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):187-91. doi: 10.1016/j.plefa.2009.05.010. Epub 2009 Jun 6.
9
Omega-3 polyunsaturated fatty acids and human health outcomes.欧米伽-3多不饱和脂肪酸与人类健康结局
Biofactors. 2009 May-Jun;35(3):266-72. doi: 10.1002/biof.42.
10
Fatty acid composition of plasma phospholipids and risk of prostate cancer.
Am J Clin Nutr. 2009 Jun;89(6):1946; author reply 1946-7. doi: 10.3945/ajcn.2009.27682. Epub 2009 Apr 15.